Development of models to predict anabolic response to testosterone administration in healthy young men

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 5 47-5, 2003, Pages

  Woodhouse, Linda J ^a   Reisz Porszasz, Suzanne ^a   Javanbakht, Marjan ^a   Storer, Thomas W ^a   Lee, Martin ^a   Zerounian, Hrant ^a   Bhasin, Shalender ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Androgen receptor genetic polymorphism; Polyglutamine repeats; Polyglycine repeats; Predicting lean body mass response to testosterone; Testosterone dose response; Testosterone effects on muscle

Indexed keywords

ANDROGEN RECEPTOR; GONADORELIN AGONIST; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE ENANTATE;

ADULT; AGE; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; GENETIC POLYMORPHISM; HORMONAL REGULATION; HUMAN; LEAN BODY WEIGHT; MALE; MORPHOMETRICS; MULTIVARIATE ANALYSIS; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0037403994     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00536.2002     Document Type: Article

References (37)

1. Alway SE, Grumbt WH, Gonyea WJ, and Stray-Gundersen J. Contrasts in muscle and myofibers of elite male and female bodybuilders. J Appl Physiol 67: 24-31, 1989.
2. Beilin J, Ball EM, Favaloro JM, and Zajac JD. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 25: 85-96, 2000.
3. Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, and Beall G. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab 83: 3155-3162, 1998.
4. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, and Casaburi R. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335: 1-7, 1996.
5. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, Lee WP, Bunnell TJ, and Casaburi R. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 82: 407-413, 1997.
6. Bhasin S, Storer TW, Javanbakht M, Berman N, Yarasheski KE, Phillips J, Dike M, Sinha-Hikim I, Shen R, Hays RD, and Beall G. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 283: 763-770, 2000.
7. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, and Storer TW. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281: E1172-E1181, 2001.
8. Brodsky IG, Balagopal P, and Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men: a clinical research center study. J Clin Endocrinol Metab 81: 3469-3475, 1996.
9. Chamberlain NL, Driver ED, and Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22: 3181-3186, 1994.
10. Choong CS, Kemppainen JA, Zhou ZX, and Wilson EM. Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol 10: 1527-1535, 1996.
11. Coodley GO and Coodley MK. A trial of testosterone therapy for HIV-associated weight loss. AIDS 11: 1347-1352, 1997.
12. Dobs AS, Cofrancesco J, Nolten WE, Danoff A, Anderson R, Hamilton CD, Feinberg J, Seekins D, Yangco B, and Rhame F. The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection. Am J Med 107: 126-132, 1999.
13. Edwards SM, Badzioch MD, Minter R, Hamoudi R, Collins N, Ardern-Jones A, Dowe A, Osborne S, Kelly J, Shearer R, Easton DF, Saunders GF, Dearnaley DP, and Eeles RA. Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int J Cancer 84: 458-465, 1999.
14. Gao T, Marcelli M, and McPhaul MJ. Transcriptional activation and transient expression of the human androgen receptor. J Steroid Biochem Mol Biol 59: 9-20, 1996.
15. Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, and Klibanski A. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 129: 18-26, 1998.
16. Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, Anderson E, Stanley T, Schoenfeld D, Burrows B, Hayden D, Basgoz N, and Klibanski A. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 133: 348-355, 2000.
17. Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, Wang J, and Pierson RN Jr. Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 52: 214-218, 1990.
18. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, and Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 81: 4358-4365, 1996.
19. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, and Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 56: M266-M272, 2001.
20. Morley JE, Perry HMd, Kaiser FE, Kraenzle D, Jensen J, Houston K, Mattammal M, and Perry HM Jr. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 41: 149-152, 1993.
21. Sih R, Morley JE, Kaiser FE, Perry HM III, Patrick P, and Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82: 1661-1667, 1997.
22. Singh AB, Hsia S, Alaupovic P, Sinha-Hikim I, Woodhouse L, Buchanan TA, Shen R, Bross R, Berman N, and Bhasin S. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab 87: 136-143, 2002.
23. Sinha Hikim AP, Bartke A, and Russell LD. Morphometric studies on hamster testes in gonadally active and inactive states: light microscope findings. Biol Reprod 39: 1225-1237, 1988.
24. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, Storer TW, Casaburi R, Shen R, and Bhasin S. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 283: E154-E164, 2002.
25. Sinha-Hikim I, Arver S, Beall G, Shen R, Guerrero M, Sattler F, Shikuma C, Nelson JC, Landgren BM, Mazer NA, and Bhasin S. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 83: 1312-1318, 1998 [published erratum in J Clin Endocrinol Metab 83: 2959, 1998].
26. Sleddens HF, Oostra BA, Brinkmann AO, and Trapman J. Trinucleotide repeat polymorphism in the androgen receptor gene (AR) (Abstract). Nucleic Acids Res 20: 1427, 1992.
27. Sleddens HF, Oostra BA, Brinkmann AO, and Trapman J. Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene (Abstract). Hum Mol Genet 2: 493, 1993.
28. Snyder PJ and Lawrence DA. Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab 51: 1335-1339, 1980.
29. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, and Strom BL. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85: 2670-2677, 2000.
30. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, and Strom BL. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84: 2647-2653, 1999.
31. Tenover JS. Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men. Baillieres Clin Endocrinol Metab 12: 419-425, 1998.
32. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, and Yong EL. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82: 3777-3782, 1997.
33. Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, and Ferrando A. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol Endocrinol Metab 269: E820-E826, 1995.
34. Van Pottelberg I, Lumbroso S, Goemaere S, Sultan C, and Kaufman JM. Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men. Clin Endocrinol (Oxf) 55: 659-666, 2001.
35. Wang C, Eyre DR, Clark R, Kleinberg D, Newman C, Iranmanesh A, Veldhuis J, Dudley RE, Berman N, Davidson T, Barstow TJ, Sinow R, Alexander G, and Swerdloff RS. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men: a clinical research center study. J Clin Endocrinol Metab 81: 3654-3662, 1996.
36. Wang C, Swedloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, and Berman N. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone gel study group. J Clin Endocrinol Metab 85: 2839-2853, 2000.
37. Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R, and Nieschlag E. The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86: 4867-4873, 2001.